30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Oliver Tracie

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Oliver Tracie's trades of Arrowhead Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-07-03 2024-07-02
PlS Planned sale
93,216 +13.1%
392.01
US$550,837 		93,216 +13.1% 392.01 US$550,837
2024-07-02 2024-07-02
PrS Proposed sale
72,516
425.46
US$3,226,314 		72,516 425.46 US$3,226,314
2024-01-08 2024-01-05
PlS Planned sale
66,564 +23.4%
264.83
US$1,073,605 		66,564 +23.4% 264.83 US$1,073,605
2024-01-05 2024-01-05
PrS Proposed sale
74
33.49
US$2,478 		74 33.49 US$2,478
2023-07-06 2023-07-03
S Sale
8,925 -12.7%
35.31
US$315,142 		8,925 -12.7% 35.31 US$315,142
2023-07-03 2023-07-03
PrS Proposed sale
8,925
35.31
US$315,150 		8,925 35.31 US$315,150